Laparoscopic splenectomy to salvage renal transplants from severe acute antibody-mediated rejection
- PMID: 23316411
- PMCID: PMC3535730
- DOI: 10.1155/2012/253173
Laparoscopic splenectomy to salvage renal transplants from severe acute antibody-mediated rejection
Abstract
Purpose. Acute antibody-mediated rejection, a complication of cross match positive and sensitized renal transplants, occurs despite the use of standard desensitization protocols. Rescue therapy consists of plasmapheresis and intravenous immunoglobulin (IVIg). In patients with preformed donor specific antibodies, rejection can be aggressive. We report here a case in which laparoscopic splenectomy was added to the standard rescue regimen. Case Report and Results. A 40-year-old Hispanic female with end stage renal disease had been receiving hemodialysis. The patient had numerous class 1 unacceptable antigens. She was scheduled to undergo an incompatible 1-1-1 mismatch living related donor kidney transplant. Preoperatively, the patient received plasmapheresis, IVIG, and thymoglobulin. There was good graft function until postoperative day 5. At that point, worsening renal function was noted. Renal biopsy was consistent with AMR. The patient became anuric and dialysis was initiated. To salvage the transplant, the patient underwent laparoscopic splenectomy. Postoperatively, renal function improved. Two years after transplant, the patient continues to have excellent graft function. Conclusion. In a small but significant number of renal transplants, antibody production occurs at a rate that traditional treatments are unable to reduce effectively. Based on our experience, the addition of splenectomy to standard rescue therapy can salvage renal transplants.
Similar articles
-
Treatment of Biopsy-Proven Acute Antibody-Mediated Rejection Using Thymoglobulin (ATG) Monotherapy and a Combination of Rituximab, Intravenous Immunoglobulin, and Plasmapheresis: Lesson Learned from Primary Experience.Clin Transpl. 2014:223-30. Clin Transpl. 2014. PMID: 26281149
-
Successful rescue of refractory, severe antibody mediated rejection with splenectomy.Transplantation. 2007 Jan 15;83(1):99-100. doi: 10.1097/01.tp.0000243739.31440.2b. Transplantation. 2007. PMID: 17220802
-
Outcome of desensitization in human leukocyte antigen- and ABO-incompatible living donor kidney transplantation: a single-center experience in more than 100 patients.Transplant Proc. 2013 May;45(4):1423-6. doi: 10.1016/j.transproceed.2013.01.081. Transplant Proc. 2013. PMID: 23726587
-
Posttransplant immunosuppression in highly sensitized patients.Contrib Nephrol. 2009;162:27-34. doi: 10.1159/000170810. Epub 2008 Oct 31. Contrib Nephrol. 2009. PMID: 19001811 Review.
-
Thymoglobulin-Resistant T-Cell-Mediated Acute Rejection in a Pregnant Renal Transplant Recipient: Case Report and Review of the Literature.Exp Clin Transplant. 2019 Jan;17(Suppl 1):159-163. doi: 10.6002/ect.MESOT2018.P38. Exp Clin Transplant. 2019. PMID: 30777545 Review.
Cited by
-
Helper T Cell (CD4+) Targeted Tacrolimus Delivery Mediates Precise Suppression of Allogeneic Humoral Immunity.Research (Wash D C). 2022 Jul 16;2022:9794235. doi: 10.34133/2022/9794235. eCollection 2022. Research (Wash D C). 2022. PMID: 35958106 Free PMC article.
-
Antibody-mediated rejection in xenotransplantation: Can it be prevented or reversed?Xenotransplantation. 2023 Jul-Aug;30(4):e12816. doi: 10.1111/xen.12816. Epub 2023 Aug 7. Xenotransplantation. 2023. PMID: 37548030 Free PMC article. Review.
-
Rational clinical trial design for antibody mediated renal allograft injury.Front Biosci (Landmark Ed). 2015 Jan 1;20(4):743-62. doi: 10.2741/4334. Front Biosci (Landmark Ed). 2015. PMID: 25553476 Free PMC article. Review.
References
-
- Gloor JM, DeGoey SR, Peneda AA, et al. Overcoming a positive crossmatch in living-donor kidney trasnplantation. American Journal of Transplantation. 2003;3(8):1017 pages, 1023 pages. - PubMed
-
- Montgomery RA, Zachary AA. Transplanting patients with a positive donor-specific crossmatch: a single center’s perspective. Pediatric Transplantation. 2004;8(6):535–542. - PubMed
-
- Montgomery RA, Zachary AA, Racusen LC, et al. Plasmapheresis and intravenous immune globulin provides effective rescue therapy for refractory humoral rejection and allows kidneys to be successfully transplanted into cross-match-positive recipients. Transplantation. 2000;70(6):887–895. - PubMed
-
- Aikawa A, Ohara T, Arai K, et al. Clinical outcome and accommodation in ABO incompatible kidney transplantation. Clinical Transplants. 2004:135–142. - PubMed
-
- Locke JE, Zachary AA, Haas M, et al. The utility of splenectomy as rescue treatment for severe acute antibody mediated rejection. American Journal of Transplantation. 2007;7(4):842–846. - PubMed
LinkOut - more resources
Full Text Sources